<DOC>
	<DOCNO>NCT01416649</DOCNO>
	<brief_summary>This study investigate effect exenatide , FDA approve medication treatment type 2 diabetes sleep duration quality . Individuals type 2 diabetes study treatment Exenatide . Enrolled individual ask come University Chicago 3-4 outpatient visit course 3-4 month .</brief_summary>
	<brief_title>Impact Exenatide Sleep Duration</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Exenatide</mesh_term>
	<criteria>Patients take diabetes medication insulin include , change medication may make deem necessary physician . Patients stable medication chronic comorbid condition ( high blood pressure , high cholesterol , etc ) eligible Patients moderate severe kidney disease history pancreatitis patient insulin exclude , Exenatide use contraindicate risky condition . Patients unstable cardiac , neurological psychiatric disease woman pregnant try get pregnant exclude . Patients severe COPD , severe neuropathy chronic pain , could impair sleep , exclude . Shift worker also exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>